Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
2.
J Clin Microbiol ; 61(12): e0100123, 2023 12 19.
Artigo em Inglês | MEDLINE | ID: mdl-38112422
3.
Artigo em Inglês | MEDLINE | ID: mdl-34204588

RESUMO

Lab safety problems have become an impeding factor that cannot be ignored in normal teaching and scientific research activities at colleges and universities. As the risk factors of lab accidents can be conceptualized as occurring at multiple levels, systematically improving and optimizing lab safety is the crucial route to accident prevention in labs. In this paper, a novel method that integrates a structural equation model (SEM) and system dynamics (SD) is presented to dynamically assess lab safety with the characteristics of insufficient data and uncertainty. On the basis of a questionnaire investigation, the SEM was utilized to determine the influencing factors on lab safety and acquire the path coefficients among these factors, which were embedded into the SD model as the weight of the influencing factors. An illustration was carried out to test and validate the proposed method, and a sensitivity analysis was also conducted to recognize variables contributing the most to the improvement of lab safety. The results demonstrated that the safety input of human and management subsystems is the most effective to improve the lab safety; meanwhile, "safety awareness", "emergency ability", "operation skills", "safety culture" and "safety training" are the top five contributing factors, which can promote lab safety in the shortest time.


Assuntos
Laboratórios , Gestão da Segurança , Prevenção de Acidentes , Acidentes , Humanos , Universidades
4.
Environ Int ; 143: 105964, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32768807

RESUMO

To increase the capacity of identifying coronavirus disease 2019 (COVID-19) infection, many Biosafety Level 2 (BSL-2) labs have been established in a short period of time for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid tests all over the world. However, their biosafety has not been evaluated, which could have been the first gateway to SARS-CoV-2 transmission. During 9-11 March 2020, the first comprehensive evaluation of the biosafety in all 89 labs qualified for conducting SARS-CoV-2 tests in Sichuan Province of China was conducted. The degree of compliance with 39 criteria in five categories was evaluated: biosafety requirements for lab activities (14 criteria), sample transfer, acceptance and management (6 criteria), waste management (9 criteria), personnel training and protection (4 criteria), and lab environmental disinfection, emergency plans and accident handling (6 criteria). Our results revealed that, although an overall median compliance rate of 94.6% for 39 criteria, only four of 89 labs met all of them. Criteria in personnel training and protection have been most satisfactorily met, followed by lab environmental disinfection, emergency plans and accident handling. The most severe risk was the lack of automatic doors at the main entrance or in core operation areas, especially among labs in CDC and hospitals. This risk, together with failure for keeping pressure in the core operation areas 25 ± 5 Pa (mainly among labs in the third-party testing agencies), may cause accidental exposure to biological agents from lab activities. Other severe risk included failure for standard labeling of SARS-CoV-2 wastes and lacking regular monitoring of sterilization effects. Our findings would provide experiences and lessons for strengthening lab biosafety in other Chinese provinces, and also serve as an important reference for many other countries where such labs are being or will be quickly built for fighting the COVID-19. The information of lab safety should be considered to be internally linked to the national intelligent syndromic surveillance system (NISSS), for better improving the safety of the labs at the greatest need and facilitating more comprehensive surveillance of risk for disease outbreak.


Assuntos
Betacoronavirus , COVID-19 , Infecções por Coronavirus , Pneumonia Viral , China , Contenção de Riscos Biológicos , Infecções por Coronavirus/epidemiologia , Humanos , Pandemias , Pneumonia Viral/epidemiologia , SARS-CoV-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA